Jana Portnow

9.1k citations
60 papers · 2.2k indexed · 1 hit paper · h-index 18
Topics
Glioma Diagnosis and Treatment (31 papers)Brain Metastases and Treatment (12 papers)CAR-T cell therapy research (12 papers)

In The Last Decade

Jana Portnow

57 papers receiving 2.2k citations

Hit Papers

Bioactivity and Safety of IL13Rα2-Redirected Chimeric Ant...20152026201820222015100200300400500

Peers

Jana Portnow
Comparison fields: 5 of 90
  • Oncology 1.2k
  • Molecular Biology 800
  • Genetics 713
  • Biomedical Engineering 538
  • Immunology 432
Replace Brenda Auffinger with:
Brenda Auffinger United States
Adam M. Sonabend United States
Serena Pellegatta Italy
Margarita Gutova United States
Martha Chekenya Norway
Renate Starr United States
Bart Thaçi United States
Moneeb Ehtesham United States
Michal T. Krauze United States
Einar Osland Vik-Mo Norway
Jana Portnow relative to Brenda Auffinger United States Brenda Auffinger's profile →
Citations per field
00.5×1.5×1.9×
Brenda Auffinger · 1×
Citations per year

Countries citing papers authored by Jana Portnow

Since Specialization
Citations

This map shows the geographic impact of Jana Portnow's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jana Portnow with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jana Portnow more than expected).

Fields of papers citing papers by Jana Portnow

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jana Portnow. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jana Portnow. The network helps show where Jana Portnow may publish in the future.

Co-authorship network of co-authors of Jana Portnow

This figure shows the co-authorship network connecting the top 25 collaborators of Jana Portnow. A scholar is included among the top collaborators of Jana Portnow based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jana Portnow. Jana Portnow is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 4
2 0
3 1
4 0
5 9
6 7
7 12
8 15
9 28
10 5
11 249
12 127
13
Bioactivity and Safety of IL13Rα2-Redirected Chimeric Antigen Receptor CD8+ T Cells in Patients with Recurrent Glioblastomabreakdown →
592
14 3
15 2
16 17
17 10
18 26
19 37
20
A randomized phase II neoadjuvant trial in patients with stages II-III and inflammatory breast cancer.
2

About Jana Portnow

Jana Portnow is a scholar working on Genetics, Biotechnology and Oncology, having authored 60 papers that have together received 2.2k indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (31 papers), Brain Metastases and Treatment (12 papers) and CAR-T cell therapy research (12 papers). The work is most often cited by research in Genetics (713 citations), Oncology (1.2k citations) and Developmental Neuroscience (96 citations). Jana Portnow has collaborated with scholars based in United States, Canada and Belgium. Frequent co-authors include Behnam Badie, Christine E. Brown, Timothy W. Synold, Massimo D’Apuzzo, Stephen J. Forman, Julie R. Ostberg, Michael E. Barish, Suzette Blanchard, Mike Y. Chen and Renate Starr. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research and Clinical Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026